cobimetinib,atezolizumab,vemurafenib
roche,exelixis
['tricotel', 'melanoma']
reinhard dummer presents tricotel trial for #melanoma brain mets. two tx cohorts based on braf status. braf wt (cohort 2) recieved braf/mek/pdl1. orr 42%. no diff if symptomatic. 70% gr 3/4 tox for triple tx. #asco22 
Associate professor in Surgery at Sahlgrenska University Hospital. @sahlgrenska @SahlgrenskaAcad @goteborgUni #wcmtm #melanoma #breastcancer #surgery